Paul Mieyal comes back to Nephros
This article was originally published in Clinica
Executive Summary
Paul Mieyal has returned to lead hemodialysis filtration specialist Nephros, filling the role of acting president, acting CEO and acting chief financial officer. Dr Mieyal had been acting CEO of the firm between 2010 and 2012, when he was replaced by John Houghton, from whom Dr Mieyal has now reprised the role. Nephros did not say why Mr Houghton was leaving or if he had another job, nor did the company comment on whether they plan to make Dr Mieyal’s new roles permanent at some point. Dr Mieyal is vice-president and director of life sciences investments at Wexford Capital; and from 2000 to 2006, was vice-president in charge of healthcare investments for Wechsler & Co, a private investment firm and registered broker dealer. In addition, the company has appointed a new chair, Daron Evans; has been a board member since 2013.